youtube_live
Q3 2026 earnings • 9:00 AM tomorrow
See detailschevron_right
ABBV34:BVMF
Abbvie Inc BDR
R$101.80
0.00%
(0.00) 1D
Oct 29, 5:10:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV34...
Open
R$96.74
High
R$101.80
Low
R$96.74
Mkt. cap
513.86B
Avg. vol.
1.27K
Volume
173.00
52-wk high
R$101.80
52-wk low
R$58.29
Shares outstanding
1.77B
No. of employees
57K
Open
R$96.74
High
R$101.80
Low
R$96.74
Mkt. cap
513.86B
Avg. vol.
1.27K
Volume
173.00
52-wk high
R$101.80
52-wk low
R$58.29
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
Traders Union
·
3 hours ago
AbbVie stock rises 1.7% after Q3 2026 earnings call announcement
Yahoo Finance
·
9 hours ago
AbbVie Stock: What 10 Years of Growth and Dividends Did for $1,000
GuruFocus
·
11 hours ago
AbbVie (ABBV) Set to Report Q3 Earnings Amid Dividend Sustainabi
Investing.com
·
13 hours ago
AbbVie stock hits all-time high at 291.65 USD
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About Abbvie Inc BDR
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com